IL10 and neoplasm: Considering that FcγRIIlow/− B cells in mouse model lacked the ability to produce protumorigenic IL-10 (ref. 16), we therefore established an ex vivo system to investigate the effects of FcγRIIlow/− B cells on human tumour immunity.